Paricalcitol and albuminuria: tread carefully

Affiliations

¹ Nephrology and Hypertension Department, Instituto Investigación Sanitaria-Fundación Jiménez Díaz and School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain; Instituto Reina Sofia de Investigaciones Nefrologicas, Madrid, Spain; Red de Investigación Renal, 28040 Madrid, Spain.
² Nephrology and Hypertension Department, Instituto Investigación Sanitaria-Fundación Jiménez Díaz and School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain; Instituto Reina Sofia de Investigaciones Nefrologicas, Madrid, Spain; Red de Investigación Renal, 28040 Madrid, Spain. Electronic address: aortiz@fjd.es.

Comment

Beatriz Fernandez-Fernandez et al. Lancet Diabetes Endocrinol. 2018 Jan.

. 2018 Jan;6(1):3-5.

doi: 10.1016/S2213-8587(17)30361-3. Epub 2017 Nov 2.

¹ Nephrology and Hypertension Department, Instituto Investigación Sanitaria-Fundación Jiménez Díaz and School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain; Instituto Reina Sofia de Investigaciones Nefrologicas, Madrid, Spain; Red de Investigación Renal, 28040 Madrid, Spain.
² Nephrology and Hypertension Department, Instituto Investigación Sanitaria-Fundación Jiménez Díaz and School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain; Instituto Reina Sofia de Investigaciones Nefrologicas, Madrid, Spain; Red de Investigación Renal, 28040 Madrid, Spain. Electronic address: aortiz@fjd.es.

No abstract available

Comment on

Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016. Parvanova A, et al. Lancet Diabetes Endocrinol. 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5. Epub 2017 Nov 2. Lancet Diabetes Endocrinol. 2018. PMID: 29104158 Clinical Trial.